Switching from long-acting injection to daily pills in schizophrenia
Part of Mental health clinical trials.
This study looks at whether people with schizophrenia who are currently stable on oral antipsychotics can switch back to daily pills from a long-acting injection (paliperidone palmitate). The goal is to see if symptoms stay controlled and daily functioning improves after the switch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with schizophrenia
- You are between 18 and 65 years old
- You are currently taking an oral antipsychotic (not clozapine) and your symptoms are stable
- You are not pregnant, planning pregnancy, or breastfeeding
- You have no other major mental health conditions or severe physical illnesses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
This study looks at long-acting (extended-release) antipsychotic medicine options in people with schizophrenia, compared with regular tablets. You may be able to join if you were already part of a related earlier study or its real-world follow-up.
This study tests whether a new long-acting injection of aripiprazole (a medication for schizophrenia) works the same as the current version. It helps understand how the drug is absorbed and may offer a more convenient treatment option for people with stable schizophrenia.
This study tests an extended-release form of the medication brexpiprazole, given as an injection, for people with schizophrenia. It aims to see how the drug moves through the body and how safe it is.
This trial tests whether taking clozapine once a day (instead of twice a day) works safely for people with schizophrenia. It may help by simplifying your dosing schedule while closely monitoring your wellbeing.
This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.